Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M180Revenue $M114Net Margin (%)-75.3Altman Z-Score-2.1
Enterprise Value $M124EPS $-0.8Operating Margin %-45.2Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.8Pre-tax Margin (%)-75.5Higher ROA y-yY
Price/Book2.510-y EBITDA Growth Rate %--Quick Ratio5.2Cash flow > EarningsY
Price/Sales1.65-y EBITDA Growth Rate %1.8Current Ratio5.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-21.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-79.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M104ROIC % (ttm)-247.2Gross Margin Increase y-yN

Gurus Latest Trades with VVUS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VVUSFirst Eagle Investment 2013-06-30 Sold Out -0.01%$10.43 - $15.1
($12.91)
$ 1.73-87%Sold Out0
VVUSFirst Eagle Investment 2013-03-31 Buy 0.01%$10.2 - $14.87
($12.43)
$ 1.73-86%New holding200,000
VVUSGeorge Soros 2012-09-30 Sold Out -0.06%$17.81 - $29.93
($23.45)
$ 1.73-93%Sold Out0
VVUSGeorge Soros 2012-06-30 Reduce-0.09%$21.5 - $28.68
($24.02)
$ 1.73-93%Reduce 64.93%150,000
VVUSGeorge Soros 2012-03-31 Buy 0.14%$9.99 - $23.78
($14.83)
$ 1.73-88%New holding427,750
VVUSGeorge Soros 2011-03-31 Sold Out $6.06 - $11.2
($7.95)
$ 1.73-78%Sold Out0
VVUSGeorge Soros 2010-12-31 Buy $5.94 - $9.78
($7.38)
$ 1.73-77%New holding19,400
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VVUS is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


VVUS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Varghese Santosh TVP, Medical & Reg Affairs 2015-07-01Sell7,899$2.32-25.43 view
Slebir John LSVP, Business Development & GC 2015-07-01Sell9,215$2.32-25.43 view
Day WesleyVP, Clinical Development 2015-07-01Sell7,881$2.32-25.43 view
Day WesleyVP, Clinical Development 2015-01-29Sell472$2.78-37.77 view
Slebir John LSVP, Business Development & GC 2015-01-29Sell630$2.78-37.77 view
MARSH GUY PVP, US Operations & GM 2015-01-29Sell238$2.78-37.77 view
Sanford Svai SCFO & Chief Accounting Officer 2015-01-29Sell472$2.78-37.77 view
NORTH TIDE CAPITAL, LLC10% Owner 2015-01-08Buy500,000$3.12-44.55 view
NORTH TIDE CAPITAL, LLC10% Owner 2015-01-06Buy476,800$3.04-43.09 view
NORTH TIDE CAPITAL, LLC10% Owner 2015-01-02Buy523,200$2.9-40.34 view

Quarterly/Annual Reports about VVUS:

News about VVUS:

Articles On GuruFocus.com
Biotech Momentum Indicators: Achaogen (AKAO), Novartis (NVS), VIVUS (VVUS) Apr 01 2015 
5-year lows: PICO Holdings Inc, Black Box Corp, Vivus, and Electro Rent Corp. Mar 29 2015 
A Look at Pharma Company Dermira's Performance Mar 27 2015 
5-year lows: Vivus, Synta Pharmaceuticals Inc, MVC Capital Inc, and Kemet Corp. Feb 08 2015 
Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
Weekly Three-Year Low Highlight: VVUS, RALY, WILN, COVS Mar 25 2014 
Billionaires Hold Four Stocks, 59% Off Sep 30 2013 
Unique Investor Kyle Bass Unloads Five May 29 2013 
Weekly Guru Bargains Highlights: FTE, VVUS, PAY, TIBX, VMW Feb 24 2013 
Weekly Guru Bargains Highlights: FTNT, VVUS, HAE, PC, TIBX Dec 09 2012 

More From Other Websites
VIVUS Announces Date of Second Quarter 2015 Update and Financial Results Conference Call Jul 23 2015
VIVUS Announces Date of Second Quarter 2015 Update and Financial Results Conference Call Jul 23 2015
VIVUS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and... Jul 21 2015
VIVUS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and... Jun 24 2015
Vivus gets a vote of confidence May 29 2015
Zogenix says former obesity drug reduced seizures in study May 27 2015
VIVUS Announces Scientific Presentations May 14 2015
VIVUS Announces Scientific Presentations May 14 2015
VIVUS INC Financials May 13 2015
10-Q for VIVUS, Inc. May 08 2015
VIVUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... May 08 2015
VIVUS INC Files SEC form 10-Q, Quarterly Report May 06 2015
VIVUS Q1 Loss Narrower-than-Expected, Revenues Beat - Analyst Blog May 06 2015
VIVUS Reports First Quarter 2015 Financial Results May 05 2015
Vivus reports 1Q loss May 05 2015
Vivus reports 1Q loss May 05 2015
VIVUS Inc Earnings Call scheduled for 4:30 pm ET today May 05 2015
VIVUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... May 05 2015
VIVUS Reports First Quarter 2015 Financial Results May 05 2015
Q1 2015 VIVUS Inc Earnings Release - After Market Close May 05 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK